✦ LIBER ✦

Approval times and the safety of new pharmaceuticals

✍ Scribed by Niklas Rudholm

Publisher: Springer
Year: 2004
Tongue: French
Weight: 245 KB
Volume: 5
Category: Article
ISSN: 1618-7598
DOI: 10.1007/s10198-004-0247-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety aspects and approvals of the firs

Safety aspects and approvals of the first JET tritium experiment

✍ A.C. Bell; M. Wykes; B.J. Green 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 737 KB

Biological safety tests for the quality

Biological safety tests for the quality control of parenteral pharmaceuticals

✍ Rakieten, Nathan 📂 Article 📅 1950 🏛 Elsevier ⚖ 265 KB

Manufacturing of Pharmaceutical Proteins

Manufacturing of Pharmaceutical Proteins || Pharmacology and Drug Safety

✍ Behme, Stefan 📂 Article 📅 2009 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 226 KB

Risk-benefit evaluation ## Clinical development determines the speed of product development Manufacturing process should be fixed before phase III j139

Efficacy and safety of immunosuppressive

Efficacy and safety of immunosuppressive drugs approved in EU through the centralised procedure

✍ Vittorio Bertele’; Carmela Buonocore; Francesca Michelacci; Maria Vitocolonna; S 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 120 KB

Safety pharmacology requirements for the

Safety pharmacology requirements for the development of human cardiac/cardiovascular pharmaceuticals

✍ Ian Mackenzie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Uncertainty and choice: the challenges o

Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost

✍ F.M. Scherer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract This paper addresses the role of uncertainty in challenges confronting the US pharmaceutical industry and its regulators. It begins with a macroeconomic overview, showing how rising health care costs, including rising ethical drug costs, squeeze the wage and salary share of national inc